159 filings
Page 4 of 8
8-K
yasv2 onk3s9rr
27 Aug 21
Entry into a Material Definitive Agreement
8:25am
8-K
ebepub 6dwa4g
9 Aug 21
Exagen Inc. Reports Second Quarter 2021 Results
4:05pm
8-K
y7mngfxx ceb1qe87j
30 Jul 21
Exagen Appoints Ana Hooker to Board of Directors
8:25am
8-K
wquarkwkm2
21 Jun 21
Submission of Matters to a Vote of Security Holders
8:30am
S-8
ltrkenxx xmf
11 May 21
Registration of securities for employees
5:15pm
8-K
vodjxj kj5qmxvx
11 May 21
Exagen Inc. Reports First Quarter 2021 Results
4:06pm
DEFA14A
5bj 168jcbn
27 Apr 21
Additional proxy soliciting materials
4:11pm
424B5
eop31umjzx
23 Mar 21
Prospectus supplement for primary offering
4:30pm
8-K
3fbv5ns0ulpdpi
23 Mar 21
Exagen Inc. Announces Proposed Public Offering of Common Stock
4:16pm
8-K
onj7uenwnqosbr
22 Mar 21
Amendments to Articles of Incorporation or Bylaws
4:20pm
424B5
48t8d
22 Mar 21
Prospectus supplement for primary offering
4:13pm
8-K
5393fuzeor5ah9
16 Mar 21
Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results
4:07pm
8-K
4rpi3l
11 Jan 21
Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results
7:00am
8-K
rojpk t031f7uf54e4a
28 Dec 20
Entry into a Material Definitive Agreement
4:06pm
EFFECT
eladf4xyghxfk09 arok
20 Nov 20
Notice of effectiveness
12:16am